izpis_h1_title_alt

Correlation between the serum concentration of vitamin A and disease severity in patients carrying p.G90D in RHO, the most frequent gene associated with dominant retinitis pigmentosa : implications for therapy with vitamin A
ID Krašovec, Tjaša (Avtor), ID Kobal, Nina (Avtor), ID Šuštar Habjan, Maja (Avtor), ID Volk, Marija (Avtor), ID Hawlina, Marko (Avtor), ID Fakin, Ana (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,94 MB)
MD5: FBBF024AF41F929E21A4738D866661FB
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/24/1/780 Povezava se odpre v novem oknu

Izvleček
The pathogenic variant p.G90D in RHO is believed to be responsible for a spectrum of phenotypes, including congenital stationary blindness (for the purpose of this study termed night blindness without degeneration; NBWD), Sector RP, Pericentral RP, and Classic RP. We present a correlation between the serum concentration of vitamin A and disease severity in patients with this variant. This prospective study involved 30 patients from 7 families (17 male; median age 46 years, range 8–73). Full ophthalmological examination including visual acuity, Goldmann perimetry, slit-lamp exam, optical coherence tomography, fundus autofluorescence, and electrophysiology was performed to determine the presenting phenotype. The serum concentration of vitamin A was determined from a fasting blood sample taken on the day of the exam, where it was found that 23.3% (7/30) of patients had NBWD, 13.3% (4/30) had Sector RP, 3.3% (1/30) had Pericentral RP, and 60% (18/30) had Classic RP. Multiple logistic regression revealed a significantly higher probability of having a milder phenotype (NBWD or Sector RP) in association with younger age (p < 0.05) and a higher concentration of vitamin A (p < 0.05). We hypothesize that vitamin A in its 11-cis-retinal form plays a role in stabilizing the constitutively active p.G90D rhodopsin and its supplementation could be a potential treatment strategy for p.G90D RHO patients.

Jezik:Angleški jezik
Ključne besede:retinitis pigmentosa, RP, vitamin A, CSNB, NBWD, congenital stationary night blindness, rhodopsin, RHO, sector RP, treatment
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:14 str.
Številčenje:Vol. 24, iss. 1, art. 780
PID:20.500.12556/RUL-155549 Povezava se odpre v novem oknu
UDK:617.7
ISSN pri članku:1422-0067
DOI:10.3390/ijms24010780 Povezava se odpre v novem oknu
COBISS.SI-ID:147522819 Povezava se odpre v novem oknu
Datum objave v RUL:05.04.2024
Število ogledov:484
Število prenosov:175
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:pigmentni retinitis, RP, vitamin A, CSNB, NBWD, prirojena stacionarna nočna slepota, rodopsin, RHO, sektor RP, zdravljenje

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-1750
Naslov:Priprava pogojev za gensko zdravljenje dednih očesnih bolezni

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj